期刊文献+

吸入一氧化氮技术治疗新生儿严重低氧血症的疗效分析 被引量:2

The effects of inhaled nitrogen oxide in severe hypoxemia of neonates
下载PDF
导出
摘要 目的:探讨吸入一氧化氮(iNO)治疗新生儿严重低氧血症的临床疗效。方法:38例重症呼吸衰竭新生儿,平均胎龄(34±6)周,体重(2 187±181)g,因在常频通气(CMV)治疗过程中出现F iO2≥0.8,平均气道压≥0.98 kPa,持续2 h以上经皮氧饱和度≤90%或氧合指数(O I)>40而采用iNO,治疗过程中监测心率、血压、动脉血气、动脉肺泡氧分压(a/A)、及氧合指数等。结果:38例患儿用iNO后2 h经皮血氧饱和度(SPaO2)均≥90%;在实施iNO治疗24 h后,动脉肺泡氧分压(a/A PaO2kPa)由0.09±0.03升至0.26±0.12,氧合指数(O I)由33±12降至9±4;所需氧浓度(F iO2%)亦由79.78±19.81,显著降至55.31±19.35。结论:iNO治疗新生儿严重低氧血症可获得显著疗效,用CMV无效后可给予iNO。 Objective: To investigate the effects of inhaled nitrogen oxide(iNO) in the neonates with severe hypoxemia.Methods: 38 newborn infants in severe hypoxemia with gestational age of 34±6 weeks,birth weight(2 187 ±181) g,were enrolled in the study.The infants were given iNO with FiO_2≥0.8,MAP≥10 cm H_2O,SPaO_2 ≤90 % lasted for more than 2 hours during the conventional mechanical ventilation(CMV) or oxygenation indexes OI40.The heart rate,arterial blood gas analysis,arterial to alveoli oxygen ratio(a/ A) and the oxygenation index were monitored during iNO.Results: After 2 hours treatment with iNO,SPaO_2 increased to 90%,24 hours later,the arterial to alveoli oxygen ratio(a/ A PaO_2 kPa) increased from 0.09±0.03 to 0.26±0.12,the oxygenation index(OI) deceased from 33±12 to 9±4,and FiO_2(%) deceased rapidly from 79.78±19.81 to 55.31±19.35.Conclusion: iNO was an effective method for neonatal infants with severe res hypoxemia.
出处 《河南医学研究》 CAS 2011年第2期167-168,171,共3页 Henan Medical Research
关键词 机械通气 低氧血症 新生儿 吸入一氧化氮 mechanical ventilation hypoxemia newborns inhaled nitrogen oxide
  • 相关文献

参考文献5

  • 1Henderson-Smart DJ, Cools F, Bhuta T, et al. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants [ J]. Cochrane Database of Systematic Reviews, 2007, 18 ( 3 ) : CD000104.
  • 2Weinberger B, Heck DE, Laskin DL, et al. Nitric oxide in the lung: therapeutic and cellular mechanisms of action [ J ]. Pharmacol Therapeutics, 1999,84 (3)4 : 401-411.
  • 3Ignarro LJ, Buga CM, Wood KS, et al. Entothelium derived relaxing factor produced and released from artery and vein in nitric oxide[ J]. Proc Natl Aead Sei USA, 1987,84(24) : 9265-9269.
  • 4Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor[J]. Nature, 1987,327(6122) : 524-526.
  • 5Moncada S, Higgs A. The L-arginine-nitric oxide pathway[ J]. N Engl J Med, 1993,329(27) : 2002-2012.

同被引文献2

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部